Cargando…
Gene expression signature of cerebellar hypoplasia in a mouse model of Down syndrome during postnatal development
BACKGROUND: Down syndrome is a chromosomal disorder caused by the presence of three copies of chromosome 21. The mechanisms by which this aneuploidy produces the complex and variable phenotype observed in people with Down syndrome are still under discussion. Recent studies have demonstrated an incre...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2678156/ https://www.ncbi.nlm.nih.gov/pubmed/19331679 http://dx.doi.org/10.1186/1471-2164-10-138 |
_version_ | 1782166830939373568 |
---|---|
author | Laffaire, Julien Rivals, Isabelle Dauphinot, Luce Pasteau, Fabien Wehrle, Rosine Larrat, Benoit Vitalis, Tania Moldrich, Randal X Rossier, Jean Sinkus, Ralph Herault, Yann Dusart, Isabelle Potier, Marie-Claude |
author_facet | Laffaire, Julien Rivals, Isabelle Dauphinot, Luce Pasteau, Fabien Wehrle, Rosine Larrat, Benoit Vitalis, Tania Moldrich, Randal X Rossier, Jean Sinkus, Ralph Herault, Yann Dusart, Isabelle Potier, Marie-Claude |
author_sort | Laffaire, Julien |
collection | PubMed |
description | BACKGROUND: Down syndrome is a chromosomal disorder caused by the presence of three copies of chromosome 21. The mechanisms by which this aneuploidy produces the complex and variable phenotype observed in people with Down syndrome are still under discussion. Recent studies have demonstrated an increased transcript level of the three-copy genes with some dosage compensation or amplification for a subset of them. The impact of this gene dosage effect on the whole transcriptome is still debated and longitudinal studies assessing the variability among samples, tissues and developmental stages are needed. RESULTS: We thus designed a large scale gene expression study in mice (the Ts1Cje Down syndrome mouse model) in which we could measure the effects of trisomy 21 on a large number of samples (74 in total) in a tissue that is affected in Down syndrome (the cerebellum) and where we could quantify the defect during postnatal development in order to correlate gene expression changes to the phenotype observed. Statistical analysis of microarray data revealed a major gene dosage effect: for the three-copy genes as well as for a 2 Mb segment from mouse chromosome 12 that we show for the first time as being deleted in the Ts1Cje mice. This gene dosage effect impacts moderately on the expression of euploid genes (2.4 to 7.5% differentially expressed). Only 13 genes were significantly dysregulated in Ts1Cje mice at all four postnatal development stages studied from birth to 10 days after birth, and among them are 6 three-copy genes. The decrease in granule cell proliferation demonstrated in newborn Ts1Cje cerebellum was correlated with a major gene dosage effect on the transcriptome in dissected cerebellar external granule cell layer. CONCLUSION: High throughput gene expression analysis in the cerebellum of a large number of samples of Ts1Cje and euploid mice has revealed a prevailing gene dosage effect on triplicated genes. Moreover using an enriched cell population that is thought responsible for the cerebellar hypoplasia in Down syndrome, a global destabilization of gene expression was not detected. Altogether these results strongly suggest that the three-copy genes are directly responsible for the phenotype present in cerebellum. We provide here a short list of candidate genes. |
format | Text |
id | pubmed-2678156 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-26781562009-05-07 Gene expression signature of cerebellar hypoplasia in a mouse model of Down syndrome during postnatal development Laffaire, Julien Rivals, Isabelle Dauphinot, Luce Pasteau, Fabien Wehrle, Rosine Larrat, Benoit Vitalis, Tania Moldrich, Randal X Rossier, Jean Sinkus, Ralph Herault, Yann Dusart, Isabelle Potier, Marie-Claude BMC Genomics Research Article BACKGROUND: Down syndrome is a chromosomal disorder caused by the presence of three copies of chromosome 21. The mechanisms by which this aneuploidy produces the complex and variable phenotype observed in people with Down syndrome are still under discussion. Recent studies have demonstrated an increased transcript level of the three-copy genes with some dosage compensation or amplification for a subset of them. The impact of this gene dosage effect on the whole transcriptome is still debated and longitudinal studies assessing the variability among samples, tissues and developmental stages are needed. RESULTS: We thus designed a large scale gene expression study in mice (the Ts1Cje Down syndrome mouse model) in which we could measure the effects of trisomy 21 on a large number of samples (74 in total) in a tissue that is affected in Down syndrome (the cerebellum) and where we could quantify the defect during postnatal development in order to correlate gene expression changes to the phenotype observed. Statistical analysis of microarray data revealed a major gene dosage effect: for the three-copy genes as well as for a 2 Mb segment from mouse chromosome 12 that we show for the first time as being deleted in the Ts1Cje mice. This gene dosage effect impacts moderately on the expression of euploid genes (2.4 to 7.5% differentially expressed). Only 13 genes were significantly dysregulated in Ts1Cje mice at all four postnatal development stages studied from birth to 10 days after birth, and among them are 6 three-copy genes. The decrease in granule cell proliferation demonstrated in newborn Ts1Cje cerebellum was correlated with a major gene dosage effect on the transcriptome in dissected cerebellar external granule cell layer. CONCLUSION: High throughput gene expression analysis in the cerebellum of a large number of samples of Ts1Cje and euploid mice has revealed a prevailing gene dosage effect on triplicated genes. Moreover using an enriched cell population that is thought responsible for the cerebellar hypoplasia in Down syndrome, a global destabilization of gene expression was not detected. Altogether these results strongly suggest that the three-copy genes are directly responsible for the phenotype present in cerebellum. We provide here a short list of candidate genes. BioMed Central 2009-03-30 /pmc/articles/PMC2678156/ /pubmed/19331679 http://dx.doi.org/10.1186/1471-2164-10-138 Text en Copyright © 2009 Laffaire et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Laffaire, Julien Rivals, Isabelle Dauphinot, Luce Pasteau, Fabien Wehrle, Rosine Larrat, Benoit Vitalis, Tania Moldrich, Randal X Rossier, Jean Sinkus, Ralph Herault, Yann Dusart, Isabelle Potier, Marie-Claude Gene expression signature of cerebellar hypoplasia in a mouse model of Down syndrome during postnatal development |
title | Gene expression signature of cerebellar hypoplasia in a mouse model of Down syndrome during postnatal development |
title_full | Gene expression signature of cerebellar hypoplasia in a mouse model of Down syndrome during postnatal development |
title_fullStr | Gene expression signature of cerebellar hypoplasia in a mouse model of Down syndrome during postnatal development |
title_full_unstemmed | Gene expression signature of cerebellar hypoplasia in a mouse model of Down syndrome during postnatal development |
title_short | Gene expression signature of cerebellar hypoplasia in a mouse model of Down syndrome during postnatal development |
title_sort | gene expression signature of cerebellar hypoplasia in a mouse model of down syndrome during postnatal development |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2678156/ https://www.ncbi.nlm.nih.gov/pubmed/19331679 http://dx.doi.org/10.1186/1471-2164-10-138 |
work_keys_str_mv | AT laffairejulien geneexpressionsignatureofcerebellarhypoplasiainamousemodelofdownsyndromeduringpostnataldevelopment AT rivalsisabelle geneexpressionsignatureofcerebellarhypoplasiainamousemodelofdownsyndromeduringpostnataldevelopment AT dauphinotluce geneexpressionsignatureofcerebellarhypoplasiainamousemodelofdownsyndromeduringpostnataldevelopment AT pasteaufabien geneexpressionsignatureofcerebellarhypoplasiainamousemodelofdownsyndromeduringpostnataldevelopment AT wehrlerosine geneexpressionsignatureofcerebellarhypoplasiainamousemodelofdownsyndromeduringpostnataldevelopment AT larratbenoit geneexpressionsignatureofcerebellarhypoplasiainamousemodelofdownsyndromeduringpostnataldevelopment AT vitalistania geneexpressionsignatureofcerebellarhypoplasiainamousemodelofdownsyndromeduringpostnataldevelopment AT moldrichrandalx geneexpressionsignatureofcerebellarhypoplasiainamousemodelofdownsyndromeduringpostnataldevelopment AT rossierjean geneexpressionsignatureofcerebellarhypoplasiainamousemodelofdownsyndromeduringpostnataldevelopment AT sinkusralph geneexpressionsignatureofcerebellarhypoplasiainamousemodelofdownsyndromeduringpostnataldevelopment AT heraultyann geneexpressionsignatureofcerebellarhypoplasiainamousemodelofdownsyndromeduringpostnataldevelopment AT dusartisabelle geneexpressionsignatureofcerebellarhypoplasiainamousemodelofdownsyndromeduringpostnataldevelopment AT potiermarieclaude geneexpressionsignatureofcerebellarhypoplasiainamousemodelofdownsyndromeduringpostnataldevelopment |